aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Cash and Short-Term Investments for the year ending December 31, 2023: USD 1.81 M

aap Implantate AG Cash and Short-Term Investments is USD 1.81 M for the year ending December 31, 2023, a 235.68% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

aap Implantate AG Cash and Short-Term Investments for the year ending December 31, 2022 was USD 539.25 K, a -79.43% change year over year.
aap Implantate AG Cash and Short-Term Investments for the year ending December 31, 2021 was USD 2.62 M, a 82.34% change year over year.
aap Implantate AG Cash and Short-Term Investments for the year ending December 31, 2020 was USD 1.44 M, a -69.50% change year over year.
aap Implantate AG Cash and Short-Term Investments for the year ending December 31, 2019 was USD 4.71 M, a -42.06% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years